Media Contact

October 122022

Water Street Invests in Global Provider of Solutions Optimizing Life Sciences Operations

Water Street Healthcare Partners announced today that it has invested in and facilitated the combination of CXV Global and Panacea Technologies. The transaction creates a leading global provider of automation and digitization solutions uniquely positioned to optimize life sciences organizations’ worldwide operations. 

As companies expand and enhance their operations to develop, produce and distribute products ranging from traditional medications to emerging therapies and advanced medical technologies, finding a provider who can address the full scope of their global operational needs is challenging. By joining forces, CXV Global and Panacea Technologies transform this dynamic. Together, they offer life sciences companies a comprehensive portfolio of technologies and professional services that maximize the efficiency of their worldwide operations across their entire product life cycle.

Powerful Platform of Combined Capabilities

CXV Global and Panacea Technologies offer a powerful platform of combined technologies and professional services that optimize life sciences’ operations across product development, manufacturing, packaging and distribution. Key features include:

  • a comprehensive portfolio of innovative automation solutions and digitization capabilities encompassing machine vision, serialization, digitization, and resourcing for R&D and manufacturing sites
  • an extensive global network anchored by a strong presence in two of the world’s largest life sciences markets: Europe and the U.S.
  • 24x7 production activity and multi-site, multi-national and multi-lingual project support spanning 10 time zones
  • high-touch service from a global workforce of 500+ employees possessing deep technical and engineering expertise

Water Street has committed significant capital to expand the new platform’s global footprint and solutions. In addition, the health care firm engaged its industry network to recruit Brendan McAtamney as chairman of the new platform. A highly accomplished pharmaceutical executive, Mr. McAtamney recently retired as CEO of UDG Healthcare following a distinguished career at Abbott Laboratories. He currently serves as chairman of Sharp Services and vice chairman of Inizio.

Brendan McAtamney, newly appointed chairman, stated:

“I am excited to be part of building a much-needed solution to advance the critical work of pharmaceutical and medical technology companies. The combination of CXV Global and Panacea’s innovative technologies and capabilities is unparalleled. Working with their talented leadership team, we have a tremendous opportunity to make a difference in our industry.”

About CXV Global

CXV Global develops and delivers proprietary solutions to automate R&D, manufacturing, packaging and distribution operations for life sciences organizations. The company began as a strategic alliance in 2020 when Crest Solutions, Xyntek Incorporated and VistaLink came together in response to customer requests for an integrated global automation solution. CXV Global operates in Ireland, Benelux, Scandinavia, the United Kingdom and the United States.

Frank Madden, co-founder and chief executive officer of CXV Global, said:

“This strategic transaction accelerates our expansion to support our customers’ growing operational demands. Since forming CXV Global in 2020, Crest, Xyntek and VistaLink have seen firsthand the greater impact we can make serving clients together. Bringing CXV Global and Panacea Technologies together under common ownership bolsters our ability to optimize and support the full scope of our clients’ product operations, from development through distribution, wherever and whenever they need."

About Panacea Technologies

Panacea Technologies specializes in world-class products and services that automate manufacturing for biopharmaceutical products, including cell and gene therapies. The company was founded in 1996 when it spearheaded the automation design for the largest biotech facility in the world. Highly regarded for its engineering expertise, Panacea has received industry awards recognizing its innovation and systems integration. The company is headquartered in Philadelphia.

Abhijit C. Jog, founder and chief executive officer of Panacea Technologies, stated:

“CXV Global’s culture and commitment to serving their customers are incredibly similar to ours. We both have developed new technologies and expanded our capabilities as our customers’ needs have grown and changed. Combining our life sciences expertise and world-class solutions is a natural next step toward advancing our work to meaningfully contribute to our customers’ goals for bringing new therapies to market."

Subscribe to Water Street News

To receive Water Street news via email,
please complete the form below.

Privacy Policy

You’ve just been sent an email to confirm your email address. Please click on the link in the email to activate your subscription.

If you do not receive an email from us within a few minutes, please check your spam folder. If our email did not come through to you, please click on this link,

Something went wrong. If you are seeing this error, please let us know, and we will get it fixed asap.